2-fluorodopa has been researched along with Basal Ganglia Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Nomura, H; Saito, H; Tanji, H; Tuji, S | 1 |
1 other study(ies) available for 2-fluorodopa and Basal Ganglia Diseases
Article | Year |
---|---|
PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Topics: Aged; Apraxias; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Tomography, Emission-Computed | 1996 |